Research News & Publications

Life-long blood production depends on hundreds of cells that form prior to birth

09/18/2017

How many blood-forming stem cells are present at birth to keep us supplied with blood cells for a lifetime? It is more than previously thought.
Antibiotic identified that reduces infection risk in young leukemia patients

09/14/2017

Prophylactic antibiotic therapy with levofloxacin is safe and effective for reducing treatment-related infections in pediatric leukemia patients.
Comprehensive study of chronic disease reveals vulnerability of childhood cancer survivors

09/07/2017

The severity and complexity of chronic disease in adult survivors of childhood cancer suggest that a new approach to healthcare delivery is needed.
St. Jude unveils powerful resource to advance treatment of pediatric solid tumors

08/30/2017

Childhood Solid Tumor Network offers the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors
HPV vaccination rates lag for vulnerable population of childhood cancer survivors

08/24/2017

Health provider recommendation most important predictor of HPV vaccination of adolescent and young adult survivors of childhood cancer.
Allergies? Exhausted regulatory T cells may play a role

08/24/2017

Regulatory T cells show evidence of functional exhaustion in research that underscores the importance of immunometabolism for immune balance.
Researchers discover fundamental pathology behind ALS

08/16/2017

Identifying the basic cellular malfunction underlying ALS opens the pathway to developing treatments to prevent the disease by preserving neurons.
Discovery points to drugs that would ‘short-circuit’ deadly leukemia

08/03/2017

St. Jude researchers have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”
St. Jude names Charalampos Kalodimos chair of Department of Structural Biology

08/02/2017

Dr. Kalodimos’ appointment will further strengthen basic science programs that serve as the foundation of discovery.
St. Jude Children's Research Hospital signs agreement to commercialize RSV vaccine

07/31/2017

Agreement with Serum Institute of India to develop a vaccine for respiratory syncytial virus, a lower respiratory tract infection in infants and children.